NTHI vs TMO · rev $40.0K vs P/E 24, rev $23.00B
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) is a biotechnology company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US. It is led by Marc N. Casper.
Latest reported NTHI revenue for 2025-12-31 was $40.0K. Net income was -$62.1M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. NTHI currently screens at market cap $117.3M.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
NTHI currently screens at market cap $117.3M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the NTHI and TMO stock pages for the full models.
Not investment advice.